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Background: Vanda tessellata (Orchidaceae) has been used in different sorts of ailments such as inflammations,
rheumatism, dysentery, bronchitis, dyspepsia and fever in folk medicine. In this study we evaluated the antinociceptive
and cytotoxic effect of methanol and aqueous extracts of V. tessellata leaf.
Methods: Oral administration of V. tessellata aqueous (VTA) and methanol (VTM) leaf extracts at 200 and 400 mg/kg
body weight (bw) doses were assessed for antinociceptive activity in acetic acid-induced writhing test, hot plate test,
and tail immersion test in mice. In this study we also screened for cytotoxicity of the extracts by the brine shrimp
(Artemia salina) lethality assay.
Results: The extracts, at both doses, exhibited a significant (p < 0.05 - < 0.01) dose-dependent antinociceptive activity
in hot plate and tail immersion test. The reaction time was increased to the thermal stimuli at 200 and 400 mg/kg
doses up to 90 min. In acetic acid-induced writhing test, oral administration of VTA and VTM (200 and 400 mg/kg)
also decreased the writhing significantly while compared to control. The dose 400 mg/kg showed maximum percentage
of pain inhibition 42.37% and 45.08% for VTA and VTM respectively. Diclofenac sodium (10 mg/kg) and nalbuphine
(10 mg/kg) were used as reference antinociceptive drugs. Very low cytotoxicity was observed on brine shrimps
lethality assay.
Conclusions: The leaf extract has potential antinociceptive activity with minimum cytotoxicity. The present study
supports the use of V. tessellata in different inflammatory disorders.
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Most analgesic drugs such as NSAIDs, COX-2 inhibitors
and opioids exhibit an extensive range of adverse effects
including gastrointestinal disorders, kidney problems
and other unwanted effects. Drug regulatory authorities
have been imposed a boxed warning on the label of
some COX-2 selective inhibitor for cardiovascular and
gastrointestinal risks [1]. Similarly, addiction and misuse
of opioids is a growing problem [2]. Analgesic choice is
also determined by the type of pain, for example, trad-
itional analgesics are less effective in neuropathic pain
[3]. Therefore, advent for safe and effective analgesic
drugs is still challenging for the researchers.* Correspondence: masud@pharm.iiuc.ac.bd
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article, unless otherwise stated.Nowadays, natural products as an alternative and com-
plementary medicine to many ailments have been a
major interest among researchers. In addition to docu-
menting the traditional knowledge related to medicinal
plants, scientific authentication of these medicinal plants
has been an important path of recent research [4].
Vanda tessellata Roxb. (Orchidaceae), locally known as
Rasna, has been used in folk medicine for its multifarious
medicinal properties [5]. It is an epiphytic perennial herb,
scandent by the stout and having simple or branching
aerial roots distributed throughout Bangladesh, Indian
subcontinent and Indochina. Leaves are succulent,
15–20 cm long, linear, recurved and complicate. Roots
are alexiteric and antipyretic and useful in dyspepsia,
bronchitis, diseases of the abdomen, bronchitis, piles,
hiccough and tremors [6]. Externally the root is used
in rheumatism and allied disorders and diseases of thentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Chowdhury et al. BMC Complementary and Alternative Medicine 2014, 14:464 Page 2 of 7
http://www.biomedcentral.com/1472-6882/14/464nervous system. It is a great panacea for oligomenor-
rhea, amenorrhea and dysmenorrheal, as it augments
uterine contractions. It is also remedy for secondary
syphilis and scorpion sting. In addition, juice of the
leaves is given in otitis and the paste as febrifuge.
Unani practitioners hold it to be laxative and tonic to
the liver. It is also used to treat boils on the scalp [7,8].
V. tessellata leaves are used in folk medicine for the
treatment of cough, edema, respiratory difficulties,
poisoning of blood due to rheumatism, fever and
paralysis in Bangladesh. Leaves of V. tessellata are
macerated with ginger slices (rhizomes of Zingiber
officinale Roscoe) and applied to affected areas and
that application for a long time gives good results in
paralysis and is satisfactory for rheumatic pain [9-11].
Experimentally, various pharmacological properties of
V. tessellata have been reported, in particular anti-
inflammatory [6,12], antimicrobial [13], anticonvulsant
[14,15], wound healing [16], antioxidant [17], hepatopro-
tective [18], antidiarrheal [19], mast cell stabilization [20],
cerebral anti-ischemic [21] and aphrodisiac [22,23] prop-
erties. Phytochemical screening of the plant has revealed
an alkaloid, a glucoside, tannins, β-sitosterol, γ-sitosterol
and a long chain aliphatic compound, fatty oils, resins
and colouring matters. Roots contain tetracosyl ferrulate
and β-sitosterol-D-glucoside [7,24]. Some bioactive com-
pounds have been isolated from V. tessellata are 2,7,7-tri
methyl bicyclo [2.2.1] heptanes [23], 17-β-hydroxy-14,20-
epoxy-1-oxo-[22R]-3β-[O-β-d-glucopyranosyl]-5,24-with-
adienolide [25], and melianin [13].
The most frequent approach to species selection for
phytochemical and/or pharmacological analysis is by
reviewing the ethnobotanical literature [26]. In view of
this evidence from the existing literatures showing that
V. tessellata has variegated traditional uses against
different sorts of diseases. Thus, the present study was
aimed to investigate the antinociceptive and cytotoxic




Vanda tessellata leaves were collected from a rustic area
(Dholia) of Feni district, Bangladesh and authenticated
by the expert of Bangladesh Forest Research Institute,
Chittagong, Bangladesh (Accession No. 4306) where a vou-
cher specimen has been deposited for further reference.
Extract preparation
After washing and cutting the leaves into small parts,
the leaves were air-dried in a shade and finally in a
mechanical drier (Ecocell, MMM Group, Germany) at
55-60°C. The dried samples were ground to course powder
with a mechanical grinder (NOWAKE, Japan). The powder(200 g) soaked in 800 ml methanol for a week at room
temperature with occasional shaking and stirring on a
shaker machine, and then filtered through a cotton plug
followed by whatman filter paper No. 1. The solvent was
evaporated under vacuum at room temperature to yield
semisolid. To prepare aqueous extract the leaf powder
(200 g) was soaked in distilled water (800 ml) overnight at
room temperature and the solvent was filtered. The filtrate
was distilled and concentrated under reduced pressure.
The final yield was 1.6% w/w (VTM) and 1.2% w/w (VTA),
respectively. The extracts were preserved in a refrigerator
till further use.
Experimental animals
Swiss albino mice, weighing about 25–30 g, were collected
from Jahangir Nagar University, Savar, Bangladesh. The
animals were provided with standard laboratory food and
distilled water ad libitum and maintained at natural
day-night cycle having proper ventilation in the room.
All the experiments were conducted in an isolated and
noiseless condition. The study protocol was approved
by the P&D Committee, Department of Pharmacy,
International Islamic University Chittagong, Bangladesh
(Pharm-P&D-37/07’12). The animals were acclimatized to
laboratory condition for 10 days prior to experimentation.
Drugs and chemicals
Diclofenac Na (MERCK, Mumbai, India), nalbuphine
(Square Pharmaceuticals Ltd., Bangladesh), formalde-
hyde (MERCK, Mumbai, India), and 0.9% NaCl saline
solution (Popular Pharmaceuticals Ltd., Bangladesh) were
used. All other reagents were of analytical grade.
Acute oral toxicity test
Acute oral toxicity test was carried out in accordance
with the Organization for Economic Cooperation and
Development (OECD) guidelines for testing of chemi-
cals, 420 [27]. Swiss albino mice maintained under
standard laboratory conditions were used for acute
toxicity study. A total of three mice from each group
received a single oral dose (5, 50, 300, and 2000 mg/kg
bw of the extract. Animals were kept over-night fast-
ing prior to administration. After administration of
the extracts (VTA and VTM), food was withheld for
further 3 to 4 h. The animals were then individually
observed (with special attention during the first 4 h)
for possible behavioral changes, allergic reactions
(skin rash, itching), eyes and mucous membrane, and
mortality for the next 72 h.
Photochemical screening
For preliminary phytochemical analysis the freshly pre-
pared crude methanol extract of leaves were dissolved in
suitable solvent and tested for the presence or absence
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tannins, saponins, phytosterols and alkaloids by using
standard phytochemical procedures [28].
Antinociceptive activity
Acetic acid-induced writhing test
For writhing test, 0.6% (v/v) acetic acid solution (10 mL/kg
body weight) was injected intraperitoneally (i.p) to each
mice of six groups (n = 5) and the number of writhing
and stretching were counted over 20 min. Group I
served as control received normal saline, Group II
received diclofenac sodium (10 mg/kg) as a standard,
group III-IV received V. tessellata aqueous extract (VTA),
and group V-VI received V. tessellata methanol extract
(VTM) at the dose of 200 and 400 mg/kg bw orally (p.o),
respectively 30 min before acetic acid injection [29].
Hot plate method
The antinociceptive activity of the extracts was also
measured by hot-plate method [30]. Mice were divided
into six groups of five animals each. Group I treated as
control (saline water 10 mg/kg), group II received standard
drug (diclofenac sodium 10 mg/kg i.p), group III-IV
received VTA and group V-VI received VTM (200 and
400 mg/kg bw p.o, respectively). The temperature of
the hot-plate was maintained at 55 ± 1°C. The mice
were placed in a 24 cm diameter glass cylinder on the
heated surface and the time between placement and
licking of the paws or jumping was recorded as the
latency. A cut off time of 20s was followed to avoid any
thermal injury to the paws and was defined as complete
analgesia. The reaction time were recorded before
(0 min) and after 15, 30, 45 and 60 min following
administration of test samples or standard drug.
Tail immersion method
Animals were screened based on their reaction time at
3–5 sec when subjected to pain stimulus. Mice were
divided into six groups of five animals each. Group I
represented as control received normal saline and group
III-IV received VTA and group V-VI received VTM (200
and 400 mg/kg bw p.o, respectively). Group II received
the standard drug nalbuphine (10 mg/kg) subcutane-
ously (s.c). The animal withdrawing tails from hot water
within 5 sec were selected for the study. The lower 3 cm
portion of the tail of mice was dipped in a water bath
(Le-Chatelier Thermostat, UK) maintaining at temperature
of 55 ± 0.5°C. The time in second (s) for tail withdrawal
from the water was taken as the reaction time and recoded
by a stopwatch at before (0 min) and after 30, 60 and
90 min the administration of test samples. A maximum
immersion time of 15 sec was maintained to prevent
thermal injury to the animals [31].In vitro cytotoxicity test
General toxicity of the extract was tested by the brine
shrimp (Artemia salina) lethality assay [32]. Artificial
sea water was prepared by dissolving 38 g of NaCl
(3.8%) in 1000 ml of distilled water and was filtered off
to obtain a clear solution. The dried cysts of the brine
shrimps were hatched in artificial seawater with strong
aeration for 48 hours. Methanol extract was dissolved in
sea water with DMSO (not exceed 0.01%) and trans-
ferred to test tubes to obtain concentrations of 12.5, 25,
50, 100, 200 and 400 μg/ml in 5 ml artificial sea water
with 20 nauplii in each test tube. Standard drug vincris-
tine sulphate was used as positive control at concentra-
tions of 5, 2.5, 1.25, 0.625, and 0.312 μg/ml. Control test
tubes were subjected to DMSO in artificial seawater at
the same concentration as in test tubes for test samples.
After 24 h incubation at 25-30°C, the number of viable
nauplii was counted using a magnifying glass. The per-
cent (%) mortality was calculated using the following
formula:
% Mortality ¼ Nt
N0
 100
Where, Nt = Number of dead nauplii after 24 hrs of
incubation, N0 = Number of total nauplii transferred
(n = 20). The Median lethal concentration (LC50) was
then determined.
Statistical analysis
The data was analyzed by one-way ANOVA followed by
Dunnet’s test to estimate significant differences between
the test and control groups with GraphPad Prism Data
Editor for Windows, Version 5.0 (GraphPad software
Inc., San Diego, CA). Values were expressed as mean ±
Standard error for mean (± SEM). p < 0.05 - 0.01 were
considered as statistically significant.
Results
Acute oral toxicity test
When a single dose of VTA and VTM was orally admin-
istered up to a concentration of 2000 mg/kg bw, no
adverse effects and mortality were observed. From the
acute oral toxicity test, it can be said that V. tessellate
has low toxicity profile.
Phytochemical screening
Phytochemical screening of the leaves extract of V.
tessellata confirmed the presence of flavonoids, phenolic
compounds, tannins and saponins.
The acetic acid-induced writhing test
The effect of aqueous and methanol extract of V. tessellata
leaves on acetic acid induced writhing test in mice was
Table 1 Effect of aqueous and methanol extract of V. tessellata leaves in acetic acid-induced writhing test in mice
Treatment Dose (mg/kg) No. of writhing % of inhibition
Control (Saline water) 10 59.80 ± 1.66 –
Diclofenac Na 10 27.40 ± 2.22** 54.18
VTA 200 41.40 ± 1.63** 30.77
VTA 400 34.46 ± 2.82** 42.37
VTM 200 40.90 ± 0.93* 31.60
VTM 400 32.84 ± 2.23* 45.08
Values are expressed as mean ± SEM; (n = 5). *p < 0.05, **p < 0.01 as compared with control. Data were processed with Dunnet’s test for multiple comparisons,
GraphPad Prism for Windows, Version 6.0. VTA = V. tessellata aqueous extract, VTM = V. tessellata methanol extract.
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0.01) decreased the number of writhing movements in-
duced by the intraperitoneal administration of the acetic
acid comparing with positive control. The highest inhib-
ition of pain exhibited by higher dose 400 mg/kg of aque-
ous and methanol extract was 42.37% and 45.08%
respectively while the standard drug, diclofenac Na, was
54.18% (10 mg/kg).Hot plate test
The reaction time of aqueous and methanol extract
increased in dose dependant manner to the thermal
stimuli. The results are shown in Table 2. The higher
dose 400 mg/kg of aqueous and methanol extract was
demonstrated the highest nociceptive inhibition of ther-
mal stimulus. The maximum reaction time of aqueous
and methanol extracts need for the response against
thermal stimuli at higher dose was 13.39 ± 0.64 and
12.61 ± 0.32 seconds at 60 and 45 minutes respectively
whereas the diclofenac Na (10 mg/kg) was 16.23 ±
1.66 seconds at 60 minutes (p < 0.01).Tail immersion test
The antinociceptive activity of leaves of V. tessellata
exhibited in tail immersion test of all two doses signifi-
cantly increased the latency period of hot water induced
thermal stimuli in a dose dependant manner given in
Table 3. The highest nociceptive inhibition of thermalTable 2 Effect of aqueous and methanol extract of V. tessella
Treatment Dose(mg/kg) 0 min 15 m
Control (Saline water) 10 3.48 ± 0.58 6.05 ± 0
Diclofenac Na 10 4.96 ± 0.34 11.37 ± 1
VTA 200 4.15 ± 0.61 8.66 ± 2
VTA 400 3.36 ± 0.88 10.15 ± 1
VTM 200 2.91 ± 0.41 9.47 ± 2
VTM 400 3.69 ± 0.31 10.68 ±
Values are expressed as mean ± SEM; (n = 5). *p < 0.05, **p < 0.01 as compared with
GraphPad Prism for Windows, Version 6.0. VTA = V. tessellata aqueous extract, VTM =stimuli of aqueous and methanol extract at a higher dose
400 mg/kg was 9.91 ± 0.88 and 9.15 ± 1.862 seconds
respectively while the inhibition time of nalbuphine was
11.93 ± 1.04 at 10 mg/kg (p < 0.01).The brine shrimp lethality assay
Cytotoxic effect of the extract is summarized in the
Figure 1. The LC50 for methanol and aqueous extract
of V. tessellata leaf were found to be 574.32 and
430.41 μg/mL respectively, and that of vincristine
sulphate was 0.74 μg/ml.Discussion
The present study evaluated the antinociceptive and
cytotoxic effects for the first time of aqueous and metha-
nol leaves extract of V. tessellata employing various
experimental test models. The study of traditionally used
plant species relieving pain should still be seen as a
logical research strategy in the search for new analgesic
drugs [33,34].
The intraperitoneal administration of agents provokes
a stereotyped behaviour characterised by abdominal
contractions and twisting of the dorso-abdominal muscles.
This is the advantageous method detecting effects
produced by weak analgesics. Writhing test is a non-
specific method for evaluation of pain [35]. In this model
endogenous mediators such as bradykinin, serotonin
and capsaicin generate pain which stimulate peripheralta leaves in hot plate test
Reaction time (sec)
in 30 min 45 min 60 min
.30 5.43 ± 0.54 5.95 ± 0.87 5.36 ± 0.55
.61* 13.97 ± 0.85** 14.90 ± 1.02* 16.23 ± 1.66**
.16 9.74 ± 1.41* 11.20 ± 0.96* 11.77 ± 0.81**
.18* 10.64 ± 2.58 12.73 ± 1.09** 13.39 ± 0.64*
.00* 9.79 ± 0.89* 10.29 ± 1.52 11.36 ± 0.63*
1.11 11.95 ± 0.85* 12.61 ± 0.32* 12.37 ± 0.51**
control. Data were processed with Dunnet’s test for multiple comparisons,
V. tessellata methanol extract.
Table 3 Effect of aqueous and methanol extract of V. tessellata leaves in tail immersion test
Treatment Dose(mg/kg)
Reaction time (sec)
0 min 30 min 60 min 90 min
Control (Saline water) 10 2.21 ± 0.10 2.5 ± 0.18 2.9 ± 0.37 2.39 ± 0.19
Nalbuphine 10 2.27 ± 0.15 6.05 ± 0.49** 9.23 ± 0.40* 11.93 ± 1.04**
VTA 200 2.87 ± 0.40 3.46 ± 0.51* 5.08 ± 0.67 6.38 ± 0.61
VTA 400 2.79 ± 0.34 4.95 ± 0.34 6.38 ± 0.55* 9.91 ± 0.88**
VTM 200 2.16 ± 0.22 2.61 ± 0.10* 5.12 ± 1.66* 4.40 ± 0.53
VTM 400 1.8 ± 0.32 6.2 ± 4.10* 5.43 ± 0.18* 8.15 ± 1.86*
Values are expressed as mean ± SEM; (n = 5). *p < 0.05, **p < 0.01 as compared with control. Data were processed with Dunnet’s test for multiple comparisons,
GraphPad Prism for Windows, Version 6.0. VTA = V. tessellata aqueous extract, VTM = V. tessellata methanol extract.
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[36,37]. Administration of VTA and VTM exhibited
significant (p < 0.05 - p < 0.01) and dose dependent re-
duction in abdominal contraction compared to control
in acetic acid-induced writhing mice. At doses of 200 and
400 mg per kg body weight, the number of writhing,
respectively, reduced by 30.77 and 42.37 for VTA, whereas
31.60, and 45.08% for VTM. A standard non-narcotic
analgesic drug, diclofenac Na, showed 54.18% inhibition of
writhing when administered to experimental animals at
doses of 10 mg/kg bw. The extract of V. tessellata may act
as an inhibitor of prostaglandin synthesis because the noci-
ceptive mechanism of abdominal writhing induced by
acetic acid involves the release of arachidonic acid metabo-
lites via cyclooxygenase (COX), and prostaglandin biosyn-
thesis [38]. Furthermore, different flavonoids also act
as antinociceptive and anti-inflammatory agents due to
their ability to inhibit arachidonic acid metabolism
[39-41]. Preliminary phytochemical screening of V. tessel-
lata qualitatively identified the presence of flavonoids,
phenolic compounds, tannins and saponins. Therefore,
flavonoids of the plant might be responsible for antinoci-
ceptive activity.Figure 1 Effects of various concentrations of V. tessellata leaves on th
tessellata aqueous extract, VTM = V. tessellata methanol extract.Nociceptive reactions towards thermal stimuli using
mice investigate both peripheral and central activity for
the detection of opioid analgesic as well as several types of
analgesic drug from spinal origin [42-44]. The evaluation
of VTA and VTM with the hot plate and tail immersion
presented the effect of extract that increased the la-
tency time both doses at 200 and 400 mg/kg after 15
and 30 minutes, respectively. The effect of VTA and
VTM at 400 mg/kg doses at 60 and 90 min were signifi-
cant (p < 0.05) in comparison to control while at dose
200 mg/kg showed fitful significant increase in latency. As
the hot plate and tail immersion test is a central antinoci-
ceptive test, it proves that extract exerts an antinociceptive
effect at least one central mechanisms. Therefore, the find-
ings from chemically and thermally-induced nociceptive
processes tested in this study shown by VTA and VTM
suggest that the extract contains bioactive compound(s)
with central and peripheral antinociceptive actions.
Cytotoxicity assay has been considered as pre-screening
assay for antimicrobial, antitumor, antimalarial and
insecticidal activities. Therefore it is suggested to be a
convenient probe for the pharmacological activities of
plant extracts [45,46]. The brine shrimps lethality assaye viability of brine shrimp nauplii after 24 hrs incubation. VTA = V.
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lata. The LC50 value for the crude extracts was found
to be very high signifying that the extract is safe at the
therapeutic doses.
Conclusions
Based on obtained results, it can be concluded that
V. tessellata leaves possess significant and dose-dependent
analgesic activity which was validated by various pain
models in this study, and has low cytotoxicity. The results
substantiate the ethnomedicinal use of V. tessellata to
palliate pain disorders. The findings of present studies
warrant further studies for isolation and identification
of the responsible bioactive component(s) and to eluci-
date the mechanism(s) lying with these effects.
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